Literature DB >> 3985291

Natural history of parathyroid carcinoma. Diagnosis, treatment, and results.

C A Wang, R D Gaz.   

Abstract

From 1948 to 1983, 28 patients with parathyroid carcinoma underwent treatment and analysis at the Massachusetts General Hospital. This represents about 2 percent of the 1,200 patients with hyperparathyroidism managed during the period. Patient ages ranged from 18 to 72 years (mean 45 years) with equal numbers of both sexes (14 women and 14 men). There are several hallmarks that are clues to an increased index of suspicion preoperatively. Nine of the patients (32 percent) presented with palpable neck masses. Eleven patients (39 percent) had a serum calcium level greater than 14 mg/100 ml. Significant elevations of the parathyroid hormone level were noted with values two to three times normal. The incidence and severity of metabolic complications were prominent. These complications included renal stones in 18 patients (64 percent), bone disease in 14 patients (50 percent), peptic ulcer disease in 5 patients (18 percent), parathyroid crisis in 4 patients (14 percent), and pancreatitis in 2 patients (7 percent). Eleven of the patients underwent previous surgical therapy at other institutions, and 17 patients had their initial operation at our institution. Cervical parathyroid carcinomas that ranged from 1.5 to 27 g and 1.5 to 6 cm were excised. The characteristic appearance was a gray-white, stone hard parathyroid mass with invasion of adjacent tissue. The outcome was favorable for 16 surviving patients, with 14 (50 percent) showing no evidence of recurrence 2 to 17 years postoperatively and 2 alive with persistent disease 3 years after operation. Twelve patients died. Of these, eight had unsuccessful initial operative intervention with capsular rupture and dissemination of cancer, one had advanced disease with mediastinal extension which was unresectable, and three died from unrelated causes. Recurrences became apparent within 6 months to 3 years after operation and unfortunately denoted incurable disease. The mean survival time after operation in patients with recurrent disease was 7.6 years, ranging from 1 to 22 years. Carcinoma of the parathyroid gland is a rare entity. Although it is difficult to diagnose preoperatively, there should be an increased index of suspicion in those hyperparathyroid patients with palpable neck masses, profound hypercalcemia (greater than 14 mg/100 ml), marked increase in the parathyroid hormone level to greater than twice normal, and significant metabolic complications. The initial operation must be aggressive yet meticulous with en bloc resection of the parathyroid tumor and all adjacent invaded tissues, avoiding capsular violation or tumor spillage.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3985291     DOI: 10.1016/s0002-9610(85)80050-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  39 in total

1.  Lymph node involvement and surgical approach in parathyroid cancer.

Authors:  Klaus-Martin Schulte; Nadia Talat; John Miell; Caje Moniz; Prakash Sinha; Salvador Diaz-Cano
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Development of a formula to predict parathyroid carcinoma in patients with primary hyperparathyroidism.

Authors:  Elias Karakas; Hans-Helge Müller; Vladimir K Lyadov; Stephanie Luz; Ralph Schneider; Matthias Rothmund; Detlef K Bartsch; Katja Schlosser
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

Review 3.  Best practice no 183. Examination of parathyroid gland specimens.

Authors:  S J Johnson; E A Sheffield; A M McNicol
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

4.  Immunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma.

Authors:  Ralph Schneider; Stefanie Bartsch-Herzog; Annette Ramaswamy; Detlef K Bartsch; Elias Karakas
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

5.  Indian primary hyperparathyroidism patients with parathyroid carcinoma do not differ in clinicoinvestigative characteristics from those with benign parathyroid pathology.

Authors:  Gaurav Agarwal; Kaushal K Prasad; Dilip K Kar; Narendra Krishnani; Rakesh Pandey; Saroj K Mishra
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

6.  Mediastinal parathyroid exploration: a clinical and pathologic study of 47 cases.

Authors:  C Wang; R D Gaz; A C Moncure
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

7.  Localization and surgical resection of metastatic parathyroid carcinoma.

Authors:  Y Fujimoto; T Obara; Y Ito; T Kodama; M Nobori; S Ebihara
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 8.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05

Review 9.  Parathyroid carcinoma: etiology, diagnosis, and treatment.

Authors:  Takahiro Okamoto; Masatoshi Iihara; Takao Obara; Toshihiko Tsukada
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 10.  Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.

Authors:  T Obara; Y Fujimoto
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.